NCT02502188View on ClinicalTrials.gov

Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis

PHASE1TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 17, 2015

Primary Completion Date

November 2, 2015

Study Completion Date

November 2, 2015

Conditions
ParapsoriasisHealthy Volunteers
Interventions
DRUG

CC-90005

DRUG

Placebo

Trial Locations (1)

78744

PPD Development, LP, Austin

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY